Ryman Healthcare's FY25 results show revenue up, losses remain
Ryman Healthcare (NZX:RYM) reported FY25 revenue of $760.7 million, a 10% increase year-over-year, but also a net loss after tax of -$436.8 million, worsened from -$169.7 million the previous year, impacted by one-off costs and non-cash write-downs. The company completed an extensive two-year financial reporting review aimed at improving transparency and comparability. Operational improvements are underway, with annualised cost savings of $23 million achieved in the second half of FY25, targeting double this amount by the end of FY26. A successful equity raise of $1.0 billion has reduced net interest-bearing debt to $1.665 billion and lowered gearing to 28.1%. The company completed a record build rate of 950 units and beds, and continues to focus on operational efficiency, portfolio review, and capital management strategies. For FY26, Ryman anticipates ORA sales between 1,100 and 1,300 and aims to double annualised cost savings to $46 million.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
News Alerts
Get instant email alerts when Ryman Healthcare publishes news
Free account required • Unsubscribe anytime